Literature DB >> 7462623

Immunoregulatory plasma low density lipoprotein: the biologic activity and receptor-binding specificity is independent of neutral lipids.

L K Curtiss, T S Edgington.   

Abstract

A normal human plasma low density lipoprotein subfraction (LDL-In), recovered within the intermediate density lipoprotein subclass of density range 1.006 to 1.019 g/ml, has previously been demonstrated to bind to a specific cell surface receptor independent of the LDL receptor and to regulate inductive events in the triggering of lymphocytes. The constituents of LDL-In that are responsible for the biologic activity and receptor-binding specificity were examined with respect to the role of sterols and other neutral lipids. Partial delipidization of LDL-In with heptane in the presence of starch permitted selective extraction of greater than 98% of the neutral lipids from the native lipoprotein particle. These partially delipidated polar lipid:protein particles were compared with native LDL-In with respect to charge, apoprotein content, suppressive activity for lymphocytes, and specific binding to the lymphocyte LDL-In receptor. The cholesterol- and glyceride-depleted LDL-In retained all characteristics of the native lipoprotein. These observations indicate that the interaction of LDL-In particles with the lymphocyte and the suppression of lymphocyte function are independent of the neutral lipid content of this bioregulatory lipoprotein, and that mechanisms other than cholesterol loading of the cell or sterol exchange with the plasma membrane must be operative.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462623

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.

Authors:  R D Bigler; M Khoo; S Lund-Katz; L Scerbo; M Esfahani
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  An immunosuppressive lipoprotein fraction from TEPC-183 bearing mice.

Authors:  L Wolfe; H F Havas; M R Fenton
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

3.  Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.

Authors:  S I Rosenfeld; C H Packman; J P Leddy
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

4.  Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes.

Authors:  Z Werb; J R Chin
Journal:  J Cell Biol       Date:  1983-10       Impact factor: 10.539

5.  Apoprotein E is synthesized and secreted by resident and thioglycollate-elicited macrophages but not by pyran copolymer- or bacillus Calmette-Guerin-activated macrophages.

Authors:  Z Werb; J R Chin
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.